| Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes (NCT02256332) | Unilever R&D | 2015-01-01 |
| A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes (NCT02806973) | Eli Lilly and Company | 2015-01-01 |
| Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes (NCT02341690) | University of Copenhagen | 2015-01-01 |
| Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy (NCT02424500) | Hygieia Research LLC | 2015-01-01 |
| Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support (NCT02160639) | American Association of Diabetes Educators | 2015-01-01 |
| Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants (NCT02608853) | Novo Nordisk A/S | 2015-01-01 |
| Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®) (NCT02321878) | Novo Nordisk A/S | 2014-12-15 |
| Acetylsalicylic Acid and Type 2 Diabetes Mellitus (NCT03341117) | Centro Universitario de Ciencias de la Salud, Mexico | 2014-12-02 |
| Mechanisms of Endothelial Dysfunction in Type 2 Diabetes (NCT02311075) | University Hospital, Rouen | 2014-12-01 |
| Patient Experiences With Injection Needles (NCT02531776) | University of Copenhagen | 2014-12-01 |
| A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus (NCT02302716) | Eli Lilly and Company | 2014-12-01 |
| Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (NCT02252965) | Merck KGaA, Darmstadt, Germany | 2014-12-01 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes (NCT02305381) | Novo Nordisk A/S | 2014-12-01 |
| Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake (NCT02791867) | Dasman Diabetes Institute | 2014-12-01 |
| Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function (NCT02471963) | University of Erlangen-Nürnberg Medical School | 2014-12-01 |
| Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care (NCT02225691) | Shanghai 6th People's Hospital | 2014-12-01 |
| The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence (NCT02324036) | University of California, Irvine | 2014-12-01 |
| Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus (NCT02229227) | GlaxoSmithKline | 2014-11-21 |
| A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms (NCT02298192) | Novo Nordisk A/S | 2014-11-21 |
| The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study (NCT01966978) | University of Texas Southwestern Medical Center | 2014-11-01 |
| Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes (NCT02317484) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2014-11-01 |
| Acute Effects of Inspiratory Muscle Exercise on Glucose Level and Glucose Variability in Patients With Type 2 Diabetes. (NCT02292810) | Hospital de Clinicas de Porto Alegre | 2014-11-01 |
| Facilitated Release of Endogenous Enterokines (NCT04215328) | University of Southern California | 2014-11-01 |
| Redox Imbalance and the Development of Cystic Fibrosis Diabetes (NCT02202876) | Emory University | 2014-11-01 |
| EMMA: Empowerment, Motivation and Medical Adherence (NCT02295696) | Steno Diabetes Center Copenhagen | 2014-11-01 |
| Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems (NCT02283411) | Abbott Diabetes Care | 2014-11-01 |
| Adipose Tissue Imaging in Type 2 Diabetes (NCT02528695) | Radboud University Medical Center | 2014-11-01 |
| Day-Night Rhythm in Human Skeletal Muscle (NCT02261168) | Maastricht University Medical Center | 2014-11-01 |
| Interval-training in Type 2 Diabetics (NCT02320526) | Rigshospitalet, Denmark | 2014-11-01 |
| Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function (NCT02650726) | Sun Yat-sen University | 2014-11-01 |
| A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes (NCT02306681) | Novo Nordisk A/S | 2014-10-30 |
| Effect of CPAP on Myocardial Dysfunction in Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Patients (NCT03221205) | Instituto Nacional de Enfermedades Respiratorias | 2014-10-15 |
| A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients. (NCT02268929) | Hoffmann-La Roche | 2014-10-14 |
| Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects (NCT02242149) | Universidade Federal do Rio de Janeiro | 2014-10-14 |
| A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes (NCT02254291) | Novo Nordisk A/S | 2014-10-02 |
| Study of REGN1193 in Patients With Type 2 Diabetes Mellitus (NCT02284425) | Regeneron Pharmaceuticals | 2014-10-01 |
| The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) (NCT02501850) | Hospital Universitari Vall d'Hebron Research Institute | 2014-10-01 |
| Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor (NCT03178591) | Chiang Mai University | 2014-10-01 |
| A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka (NCT01957592) | Novo Nordisk A/S | 2014-10-01 |
| The Features Behind the Beneficial Effects of Interval-walking (NCT02257190) | Rigshospitalet, Denmark | 2014-10-01 |
| Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus (NCT02284269) | Pharmaceuticals and Medical Devices Agency, Japan | 2014-10-01 |
| Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes (NCT02388113) | Norwegian University of Science and Technology | 2014-10-01 |
| A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes (NCT02230631) | Novo Nordisk A/S | 2014-10-01 |
| Resilient, Empowered, Active Living: REAL Diabetes Study (NCT02214641) | University of Southern California | 2014-10-01 |
| Linagliptin as Add on to Basal Insulin in the Elderly (NCT02240680) | Boehringer Ingelheim | 2014-09-23 |
| Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia (NCT01267448) | Cook County Health | 2014-09-09 |
| Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT02009488) | Janssen Research & Development, LLC | 2014-09-08 |
| Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight (NCT02557022) | University of Toronto | 2014-09-01 |
| Cardiorespiratory Fitness Using Electrically Assisted Bicycles (NCT03143764) | University of Bergen | 2014-09-01 |
| A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care (NCT02487888) | Proove Bioscience, Inc. | 2014-09-01 |
| The Role and Effectiveness of Diabetes Coaches in British Columbia (NCT02247271) | University of Victoria | 2014-09-01 |
| Vascular Lifestyle-Intervention and Screening in Pharmacy (NCT02223793) | University of Oslo | 2014-09-01 |
| Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes (NCT02423434) | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 2014-09-01 |
| A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients (NCT02202161) | GlaxoSmithKline | 2014-08-27 |
| New IR Biomarkers (Myokines) in Colombian People (NCT03244449) | University of Los Andes, Columbia | 2014-08-26 |
| A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (NCT02205528) | Novo Nordisk A/S | 2014-08-18 |
| Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills (NCT02128854) | Medical University of South Carolina | 2014-08-14 |
| A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes (NCT02212067) | Novo Nordisk A/S | 2014-08-11 |
| Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT02210871) | Novo Nordisk A/S | 2014-08-07 |
| A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes (NCT02207374) | Novo Nordisk A/S | 2014-08-04 |
| Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes (NCT02128932) | Novo Nordisk A/S | 2014-08-04 |
| Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus (NCT02204384) | Hospital de Clinicas de Porto Alegre | 2014-08-01 |
| Promoting Healthy Habits With Elderlies Diabetics (NCT02771821) | Universidade Federal de Pernambuco | 2014-08-01 |
| Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM (NCT02227212) | Sanofi | 2014-08-01 |
| Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland (NCT05787457) | Insel Gruppe AG, University Hospital Bern | 2014-07-31 |
| Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin (NCT02197078) | Boehringer Ingelheim | 2014-07-30 |
| 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension (NCT02182830) | Boehringer Ingelheim | 2014-07-25 |
| Diabetes Self-Management & Support LIVE (NCT02040038) | Duke University | 2014-07-01 |
| The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones (NCT02180334) | Seoul National University Hospital | 2014-07-01 |
| Practice Based Nutrition Intervention-2 (NCT01700868) | Physicians Committee for Responsible Medicine | 2014-07-01 |
| Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin (NCT02150824) | Boehringer Ingelheim | 2014-07-01 |
| Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes (NCT02481141) | SBI Pharmaceuticals Co, Ltd. | 2014-07-01 |
| A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics (NCT02197520) | Eli Lilly and Company | 2014-07-01 |
| Educational Efficacy Assessment of a Serious Game to Teach Insulin Therapy to Primary Care Physicians (NCT01759953) | Universidade Estadual de Londrina | 2014-07-01 |
| A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin (NCT02131272) | Novo Nordisk A/S | 2014-06-11 |
| Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness (NCT02167620) | Centre for Addiction and Mental Health | 2014-06-01 |
| A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects (NCT02163278) | National Health Research Institutes, Taiwan | 2014-06-01 |
| A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes (NCT02806960) | Eli Lilly and Company | 2014-06-01 |
| Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus (NCT02121483) | Boehringer Ingelheim | 2014-06-01 |
| A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects (NCT02161588) | Novo Nordisk A/S | 2014-06-01 |
| Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer (NCT03583593) | Catalysis SL | 2014-05-23 |
| A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes (NCT02147431) | Novo Nordisk A/S | 2014-05-21 |
| A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects (NCT02146079) | Novo Nordisk A/S | 2014-05-21 |
| Pharmacokinetics of Metformin Intolerance (NCT03361878) | NHS Tayside | 2014-05-04 |
| Disruption of Immune Homeostasis in Type 2 Diabetics With Generalized Chronic Periodontitis (NCT02172716) | University of Sao Paulo | 2014-05-01 |
| REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs (NCT01803828) | University of Roma La Sapienza | 2014-05-01 |
| Arterial Stiffness and Complication Risk in Type 2 Diabetes (NCT02001532) | Aarhus University Hospital | 2014-05-01 |
| Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns (NCT02138097) | Boehringer Ingelheim | 2014-05-01 |
| Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy (NCT02140645) | Boehringer Ingelheim | 2014-05-01 |
| The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy (NCT02798172) | Fourth People's Hospital of Shenyang | 2014-05-01 |
| MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes (NCT02545062) | Clalit Health Services | 2014-05-01 |
| Web-Based Collaborative Care for Patients With Diabetes and Depression (NCT01985711) | Beijing Anzhen Hospital | 2014-05-01 |
| A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes (NCT02152371) | Eli Lilly and Company | 2014-05-01 |
| Sardine-enriched Diet for Prevention Type 2 Diabetes (NCT03557541) | Institut d'Investigacions Biomèdiques August Pi i Sunyer | 2014-05-01 |
| A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes (NCT02097277) | Bristol-Myers Squibb | 2014-04-15 |
| A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus (NCT02111096) | Eli Lilly and Company | 2014-04-01 |
| Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes (NCT01578837) | Unity Health Toronto | 2014-04-01 |
| Validation of a Patient Decision Aid for Type 2 Diabetes (NCT02110979) | EPI-Q | 2014-04-01 |
| Sequencing T-cells in Type I Diabetes Mellitus (NCT02040337) | Seton Healthcare Family | 2014-04-01 |
| Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes (NCT01867502) | Hospital de Clinicas de Porto Alegre | 2014-04-01 |